Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Celldex Therapeutics buy Rouvenhey

Start price
€2.27
26.02.20 / 50%
Target price
€3.00
04.11.21
Performance (%)
566.52%
End price
€15.13
05.11.20
Summary
This prediction ended on 05.11.20 with a price of €15.13. With a performance of 566.52% the BUY prediction by Rouvenhey was a big success. Rouvenhey has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Celldex Therapeutics -3.825% -3.825% 7.317% 39.572%
iShares Core DAX® -0.992% -3.231% 11.661% 16.545%
iShares Nasdaq 100 -0.225% -3.339% 36.491% 43.334%
iShares Nikkei 225® -0.736% -7.859% 18.597% 4.253%
iShares S&P 500 -0.509% -2.979% 26.341% 40.911%

Comments by Rouvenhey for this prediction

In the thread Celldex Therapeutics diskutieren
Prediction Buy
Perf. (%) 566.52%
Target price 3.000
Change
Ends at 04.11.21

Buy mit Kursziel 3,0